KIF18A and neoplasm: Notably, genomic analyses of TCGA tumours indicate that a high proportion of LUAD (59%) and LUSC (64%) exhibit WGD and signatures of CIN, implicating their susceptibility to KIF18A- and Eg5-targeted drugs [13,14,15].